# BioNTech said in March its two co-founders and leading executives will leave by the end of the year to start a new venture.

*biotech · news · 2026-05-05 · Reuters*

## Key points

- BioNTech will exit operations in Idar-Oberstein, Marburg, and Tuebingen by the end of 2027.
- Singapore operations will end in the first quarter of 2027, according to the company statement.
- BioNTech plans to achieve up to 500 million euros in annual cost savings by 2029.
- The company will repurchase up to $1 billion of its own shares over the next 12 months.
- BioNTech reported a first-quarter net loss of 532 million euros this year.

**Companies:** BioNTech
**Countries:** Germany, Singapore

[Read the full story on Reuters](https://www.reuters.com/legal/litigation/biontech-close-sites-germany-singapore-affecting-1860-staff-2026-05-05/)

---

Canonical: https://newsio.io/n/39bf2b67-12cf-4f23-926b-3e184fa7dd09/biontech-said-in-march-its-two-co-founders-and-leading-executives-will-leave-by
Summarized by Newsio from Reuters. https://newsio.io/how-it-works